Moderna on Tuesday announced that its coronavirus vaccine was found to be safe and 100% effective at protecting against COVID-19 in a Phase 3 trial of more than 3,700 participants between the ages of 12 and 17.
- If approved by the U.S. Food and Drug Administration, it would increase the number of available vaccines for teenagers before the school year starts, per CNBC.
- Moderna’s vaccine is the second to show high efficacy in younger age groups, following Pfizer, which received an FDA emergency use authorization for adolescents earlier this month.